The Rational Engineered Bacteria Based Biohybrid Living System for Tumor Therapy

Area of Science:

• Biomedical Engineering
• Oncology
• Microbiology

Background:

• Bacterial living therapy is emerging as a potent strategy for tumor treatment.
• Bacteria possess natural tumor-homing abilities and can stimulate immune responses.
• Engineered bacteria serve as biohybrid living carriers for targeted delivery, especially in hypoxic tumor environments.

Purpose of the Study:

• To review the antitumor effects and applications of bacteria as living therapeutic agents.
• To explore various bacterial species utilized in cancer therapy and their mechanisms.
• To discuss genetically modified bacteria and their role as living delivery systems for antitumor agents.

Main Methods:

• Review of existing literature on bacterial cancer therapy.
• Analysis of mechanisms underlying bacterial antitumor and immunological effects.
• Exploration of bacterial engineering and combination with nanomaterials for enhanced cancer treatment.

Main Results:

• Bacterial cells demonstrate intrinsic advantages for targeting tumors and eliciting immune responses.
• Engineered bacterial cells can be designed for enhanced tumor therapy and minimized toxicity.
• Combination of bacteria with nanomaterials offers synergistic effects in cancer treatment.

Conclusions:

• Living therapy based on bacterial cells represents a rapidly developing field in tumor treatment.
• Bacterial cancer therapy holds significant potential for future clinical applications.
• Rational design of bacterial therapeutics is key to advancing cancer treatment strategies.